Primary record
4-(4-methyl-1,4-diazepan-1-yl)-N-[(5-methylpyrazin-2-yl)methyl]-8-oxo-11-thia-1,3-diazatetracyclo[8.7.0.0(2),?.0(1)(2),(1)?]heptadeca-2,4,6,9,12,14,16-heptaene-9-carboxamide
- 库存
- 1,597 克
- 纯度
- 99.3 %
- CAS
- 1138549-36-6
化合物标识与属性
- CAS
- 1138549-36-6
- PubChem CID
- 25257557
- SMILES
- CC1=CN=C(C=N1)CNC(=O)C2=C3N(C4=CC=CC=C4S3)C5=C(C2=O)C=CC(=N5)N6CCCN(CC6)C
- Canonical SMILES
- Cc1cnc(CNC(=O)c2c(=O)c3ccc(N4CCCN(C)CC4)nc3n3c2sc2ccccc23)cn1
名称与同义词
- CX-5461
- Pidnarulex
- 1138549-36-6
- CX5461
- CX 5461
- 3R4C5YLB9I
- Pidnarulex [WHO-DD]
- cc-1
- UNII-3R4C5YLB9I
- PIDNARULEX [INN]
- RefChem:128984
- CX-5461 (Standard)
- D0B7LU
- Pol I Inhibitor CX5461
- MFCD21609261
- 2-(4-methyl-1,4-diazepan-1-yl)-N-((5-methylpyrazin-2-yl)methyl)-5-oxo-5H-benzo[4,5]thiazolo[3,2-a][1,8]naphthyridine-6-carboxamide
- C27H27N7O2S
- CHEBI:156287
- DTXSID20150591
- orb1306482
- CHEMBL4303309
- DTXCID5073082
- RNA Pol I Inhibitor CX5461
- SCHEMBL12254622
- SCHEMBL29412931
- SCHEMBL29419980
- SCHEMBL29697313
- SCHEMBL31554851
- CHEBI:95090
- SYN3031
- XGPBJCHFROADCK-UHFFFAOYSA-N
- GLXC-90042
- HMS3426K15
- AOB87721
- BCP02547
- CS-0568
- EX-A1303
- ABP000959
- HY-13323R
- NSC782164
- s2684
- AKOS026750351
- ZINC100015134
- BCP9000561
- NSC-782164
- RL00546
- SB17209
- CX-5461/CX5461/
- NCGC00346627-01
- NCGC00346627-04
- NCGC00346627-08
- 4CA-0419
- AC-32745
- AK473866
- AS-16363
- BC168026
- BC638845
- CID:25257557
- CX-5461?
- HY-13323
- SY122295
- SID:482324324
- AB0035871
- A8337
- Y0304
- J3.418.866A
- A11065
- H11164
- W-5852
- 2-(4-methyl-1,4-diazepan-1-yl)-N-[(5-methylpyrazin-2-yl)methyl]-5-oxo-[1,3]benzothiazolo[3,2-a][1,8]naphthyridine-6-carboxamide
- A894301
- C557717
- RNA ppolymerase I inhibitor (oral, cancer), Cylene
- BRD-K12787259-001-04-3
- CX-5461,CAS:1138549-36-6
- Q27166854
- 2-(4-Methyl-1,4-diazepan-1-yl)-N-((5-methylpyrazin-2-yl)methyl)-5-oxo-5H-benzo(4,5)thiazolo(3,2-a)(1,8)naphthyridine-6-carboxamide
- 2-(Hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-N-[(5-methyl-2-pyrazinyl)methyl]-5-oxo-5H-benzothiazolo[3,2-a][1,8]naphthyridine-6-carboxamide
- 1138549-36-6 pound not CX5461 pound not CX 5461
- 2-(4-methyl-1,4-diazepan-1-yl)-N-[(5-methylpyrazin-2-yl)methyl]-5-oxo-5H-[1,3]benzothiazolo[3,2-a][1,8]naphthyridine-6-carboxamide
- 5H-BENZOTHIAZOLO(3,2-A)(1,8)NAPHTHYRIDINE-6-CARBOXAMIDE, 2-(HEXAHYDRO-4-METHYL-1H-1,4-DIAZEPIN-1-YL)-N-((5-METHYL-2-PYRAZINYL)METHYL)-5-OXO-
- 2-(4-Methyl-1,4-diazepan-1-yl)-N-((5-methylpyrazin-2-yl)methyl)-5-oxo-(1,3)benzothiazolo(3,2-a)(1,8)naphthyridine-6-carboxamide
- 2-(4-Methyl-1,4-diazepan-1-yl)-N-((5-methylpyrazin-2-yl)methyl)-5-oxo-5H-benzo[4,5]thiazolo[3,2-a][1
- 2-(4-methyl-1,4-diazepan-1-yl)-N-[(5-methylpyrazin-2-yl)methyl]-5-oxo-[1,3]benzothiazolo[3,2-a][1,8]
- 2-(4-Methyl-1,4-diazepan-1-yl)-N-[(5-methylpyrazin-2-yl)methyl]-5-oxo-5H-benzo[4,5]thiazolo[3,2-a][1,8]naphthyridine-6-carboxamide
- 2-(4-Methylhexahydro-1H-1,4-diazepine-1-yl)-N-[(5-methylpyrazine-2-yl)methyl]-5-oxo-1,11b-diaza-7-thia-5H-benzo[c]fluorene-6-carboxamide
- 4-(4-methyl-1,4-diazepan-1-yl)-N-[(5-methylpyrazin-2-yl)methyl]-8-oxo-11-thia-1,3-diazatetracyclo[8.7.0.0(2),?.0(1)(2),(1)?]heptadeca-2,4,6,9,12,14,16-heptaene-9-carboxamide
- 4-(4-methyl-1,4-diazepan-1-yl)-N-[(5-methylpyrazin-2-yl)methyl]-8-oxo-11-thia-1,3-diazatetracyclo[8.7.0.0^{2,7}.0^{12,17}]heptadeca-2,4,6,9,12,14,16-heptaene-9-carboxamide
- 4-(4-methyl-1,4-diazepan-1-yl)-N-[(5-methylpyrazin-2-yl)methyl]-8-oxo-11-thia-1,3-diazatetracyclo[8.7.0.02,7.012,17]heptadeca-2,4,6,9,12,14,16-heptaene-9-carboxamide